Congratulations! 2 new multiplex kits receive CE-IVD approval
LifeReal2022-05-06
Lifereal Biotechnology announced today that 2 new multiplex kits, 2019-nCoV / Influenza / RSV and Neisseria Gonorrhoeae / Chlamydia Trachomatis / Ureaplasma are now CE-IVD marked for in-vitro diagnostics use, as of March 25, 2022.